{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T04:15:57Z","timestamp":1785644157023,"version":"3.56.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T00:00:00Z","timestamp":1731024000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T00:00:00Z","timestamp":1731024000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["24ek0109513h0004"],"award-info":[{"award-number":["24ek0109513h0004"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22K09398"],"award-info":[{"award-number":["22K09398"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["19K09646"],"award-info":[{"award-number":["19K09646"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Bone Miner Metab"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s00774-024-01563-x","type":"journal-article","created":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T04:45:50Z","timestamp":1731041150000},"page":"74-85","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Meclozine and growth hormone ameliorate bone length and quality in experimental models of achondroplasia"],"prefix":"10.1007","volume":"43","author":[{"given":"Kenta","family":"Sawamura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4540-1556","authenticated-orcid":false,"given":"Masaki","family":"Matsushita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryusaku","family":"Esaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Mishima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasunari","family":"Kamiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kinji","family":"Ohno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Kitoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiro","family":"Imagama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,8]]},"reference":[{"key":"1563_CR1","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/0092-8674(94)90302-6","volume":"78","author":"R Shiang","year":"1994","unstructured":"Shiang R, Thompson LM, Zhu YZ, Church DM, Fielder TJ, Bocian M, Winokur ST, Wasmuth JJ (1994) Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia. Cell 78:335\u2013342","journal-title":"Cell"},{"key":"1563_CR2","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/371252a0","volume":"371","author":"F Rousseau","year":"1994","unstructured":"Rousseau F, Bonaventure J, Legeai-Mallet L, Pelet A, Rozet JM, Maroteaux P, Le Merrer M, Munnich A (1994) Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia. Nature 371:252\u2013254","journal-title":"Nature"},{"key":"1563_CR3","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/s41574-021-00595-x","volume":"18","author":"R Savarirayan","year":"2022","unstructured":"Savarirayan R, Ireland P, Irving M, Thompson D, Alves I et al (2022) International Consensus Statement on the diagnosis, multidisciplinary management and lifelong care of individuals with achondroplasia. Nat Rev Endocrinol 18:173\u2013189","journal-title":"Nat Rev Endocrinol"},{"key":"1563_CR4","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s00774-021-01298-z","volume":"40","author":"H Kitoh","year":"2022","unstructured":"Kitoh H, Matsushita M, Mishima K, Kamiya Y, Sawamura K (2022) Disease-specific complications and multidisciplinary interventions in achondroplasia. J Bone Miner Metab 40:189\u2013195","journal-title":"J Bone Miner Metab"},{"key":"1563_CR5","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1038\/s41436-021-01287-7","volume":"23","author":"R Savarirayan","year":"2021","unstructured":"Savarirayan R, Tofts L, Irving M, Wilcox WR, Bacino CA et al (2021) Safe and persistent growth-promoting effects of vosoritide in children with achondroplasia: 2-year results from an open-label, phase 3 extension study. Genet Med 23:2443\u20132447","journal-title":"Genet Med"},{"key":"1563_CR6","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/S2352-4642(23)00265-1","volume":"8","author":"R Savarirayan","year":"2024","unstructured":"Savarirayan R, Wilcox WR, Harmatz P, Phillips J 3rd, Polgreen LE et al (2024) Vosoritide therapy in children with achondroplasia aged 3\u201359 months: a multinational, randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Child Adolesc Health 8:40\u201350","journal-title":"Lancet Child Adolesc Health"},{"key":"1563_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0081569","volume":"8","author":"M Matsushita","year":"2013","unstructured":"Matsushita M, Kitoh H, Ohkawara B, Mishima K, Kaneko H, Ito M, Masuda A, Ishiguro N, Ohno K (2013) Meclozine facilitates proliferation and differentiation of chondrocytes by attenuating abnormally activated FGFR3 signaling in achondroplasia. PLoS ONE 8:e81569","journal-title":"PLoS ONE"},{"key":"1563_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.694018","volume":"9","author":"G Takemoto","year":"2022","unstructured":"Takemoto G, Matsushita M, Okamoto T, Ito T, Matsuura Y, Takashima C, Chen-Yoshikawa TF, Ebi H, Imagama S, Kitoh H, Ohno K, Hosono Y (2022) Meclozine attenuates the MARK pathway in mammalian chondrocytes and ameliorates FGF2-induced bone hyperossification in larval zebrafish. Front Cell Dev Biol 9:694018","journal-title":"Front Cell Dev Biol"},{"key":"1563_CR9","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1210\/en.2014-1914","volume":"156","author":"M Matsushita","year":"2015","unstructured":"Matsushita M, Hasegawa S, Kitoh H, Mori K, Ohkawara B, Yasoda A, Masuda A, Ishiguro N, Ohno K (2015) Meclozine promotes longitudinal skeletal growth in transgenic mice with achondroplasia carrying a gain-of-function mutation in the FGFR3 gene. Endocrinology 156:548\u2013554","journal-title":"Endocrinology"},{"key":"1563_CR10","doi-asserted-by":"publisher","first-page":"7371","DOI":"10.1038\/s41598-017-07044-8","volume":"7","author":"M Matsushita","year":"2017","unstructured":"Matsushita M, Esaki R, Mishima K, Ishiguro N, Ohno K, Kitoh H (2017) Clinical dosage of meclozine promotes longitudinal bone growth, bone volume, and trabecular bone quality in transgenic mice with achondroplasia. Sci Rep 7:7371","journal-title":"Sci Rep"},{"key":"1563_CR11","doi-asserted-by":"publisher","first-page":"ziae018","DOI":"10.1093\/jbmrpl\/ziae018","volume":"8","author":"H Funahashi","year":"2024","unstructured":"Funahashi H, Matsushita M, Esaki R, Mishima K, Ohkawara B, Kamiya Y, Takegami Y, Ohno K, Kitoh H, Imagama S (2024) Long-term oral meclozine administration improves survival rate and spinal canal stenosis during postnatal growth in a mouse model of achondroplasia in both sexes. JBMR Plus 8:ziae018","journal-title":"JBMR Plus"},{"key":"1563_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0229639","volume":"15","author":"H Kitoh","year":"2020","unstructured":"Kitoh H, Matsushita M, Mishima K, Nagata T, Kamiya Y, Ueda K, Kuwatsuka Y, Morikawa H, Nakai Y, Ishiguro N (2020) Pharmacokinetics and safety after once and twice a day doses of meclizine hydrochloride administered to children with achondroplasia. PLoS ONE 15:e0229639","journal-title":"PLoS ONE"},{"key":"1563_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0283425","volume":"18","author":"M Matsushita","year":"2023","unstructured":"Matsushita M, Kitoh H, Mishima K, Kamiya Y, Kato D, Takemoto G, Sawamura K, Ueno S, Yasuhiro N, Nishida K, Imagama S (2023) Phase 1b study on the repurposing of meclizine hydrochloride for children with achondroplasia. PLoS ONE 18:e0283425","journal-title":"PLoS ONE"},{"key":"1563_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2020.111052","volume":"519","author":"M Dixit","year":"2021","unstructured":"Dixit M, Poudel SB, Yakar S (2021) Effects of GH\/IGF axis on bone and cartilage. Mol Cell Endocrinol 519:111052","journal-title":"Mol Cell Endocrinol"},{"key":"1563_CR15","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/281544a0","volume":"281","author":"DV Goeddel","year":"1979","unstructured":"Goeddel DV, Heyneker HL, Hozumi T, Arentzen R, Itakura K, Yansura DG, Ross MJ, Miozzari G, Crea R, Seeburg PH (1979) Direct expression in Escherichia coli of a DNA sequence coding for human growth hormone. Nature 281:544\u2013548","journal-title":"Nature"},{"key":"1563_CR16","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/nrendo.2018.22","volume":"14","author":"MB Ranke","year":"2018","unstructured":"Ranke MB, Wit JM (2018) Growth hormone: past, present and future. Nat Rev Endocrinol 14:285\u2013300","journal-title":"Nat Rev Endocrinol"},{"key":"1563_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.811846","volume":"12","author":"S Cianfarani","year":"2021","unstructured":"Cianfarani S (2021) Safety of pediatric rhGH therapy: an overview and the need for long-term surveillance. Front Endocrinol (Lausanne) 12:811846","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1563_CR18","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1080\/08035250510039982","volume":"94","author":"NT Hertel","year":"2005","unstructured":"Hertel NT, Ekl\u00f6f O, Ivarsson S, Aronson S, Westphal O, Sipil\u00e4 I, Kaitila I, Bland J, Veimo D, M\u00fcller J, Mohnike K, Neumeyer L, Ritzen M, Hagen\u00e4s L (2005) Growth hormone treatment in 35 prepubertal children with achondroplasia: a five-year dose-response trial. Acta Paediatr 94:1402\u20131410","journal-title":"Acta Paediatr"},{"key":"1563_CR19","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1007\/s00431-017-2923-y","volume":"176","author":"D Harada","year":"2017","unstructured":"Harada D, Namba N, Hanioka Y, Ueyama K, Sakamoto N, Nakano Y, Izui M, Nagamatsu Y, Kashiwagi H, Yamamuro M, Ishiura Y, Ogitani A, Seino Y (2017) Final adult height in long-term growth hormone-treated achondroplasia patients. Eur J Pediatr 176:873\u2013879","journal-title":"Eur J Pediatr"},{"key":"1563_CR20","doi-asserted-by":"publisher","first-page":"4977","DOI":"10.1242\/dev.125.24.4977","volume":"125","author":"MC Naski","year":"1998","unstructured":"Naski MC, Colvin JS, Coffin JD, Ornitz DM (1998) Repression of hedgehog signaling and BMP4 expression in growth plate cartilage by fibroblast growth factor receptor 3. Development 125:4977\u20134988","journal-title":"Development"},{"key":"1563_CR21","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1359\/JBMR.050108","volume":"20","author":"D King","year":"2005","unstructured":"King D, Jarjoura D, McEwen HA, Askew MJ (2005) Growth hormone injections improve bone quality in a mouse model of osteogenesis imperfecta. J Bone Miner Res 20:987\u2013993","journal-title":"J Bone Miner Res"},{"key":"1563_CR22","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1117\/12.480417","volume":"5031","author":"K Mori","year":"2003","unstructured":"Mori K, Suenaga Y, Toriwaki J (2003) Fast software-based volume rendering using multimedia instructions on PC platforms and its application to virtual endoscopy. Proc SPIE 5031:111\u2013122","journal-title":"Proc SPIE"},{"key":"1563_CR23","doi-asserted-by":"publisher","first-page":"E1339","DOI":"10.1152\/ajpendo.00272.2009","volume":"297","author":"T Kake","year":"2009","unstructured":"Kake T, Kitamura H, Adachi Y, Yoshioka T, Watanabe T, Matsushita H, Fujii T, Kondo E, Tachibe T, Kawase Y, Jishage K, Yasoda A, Mukoyama M, Nakao K (2009) Chronically elevated plasma C-type natriuretic peptide level stimulates skeletal growth in transgenic mice. Am J Physiol Endocrinol Metab 297:E1339-1348","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"1563_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.bonr.2020.100708","volume":"13","author":"S Kaneko","year":"2020","unstructured":"Kaneko S, Matsushita M, Mishima K, Takegami Y, Imagama S, Kitoh H (2020) Effect of periosteal resection on longitudinal bone growth in a mouse model of achondroplasia. Bone Rep 13:100708","journal-title":"Bone Rep"},{"key":"1563_CR25","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1093\/hmg\/dds065","volume":"21","author":"OE Mugniery","year":"2012","unstructured":"Mugniery OE, Dacquin R, Marty C, Benoist-Lasselin C, de Vernejoul MC, Jurdic P, Munnich A, Geoffroy V, Legeai-Mallet L (2012) An activating Fgfr3 mutation affects trabecular bone formation via a paracrine mechanism during growth. Hum Mol Genet 21:2503\u20132513","journal-title":"Hum Mol Genet"},{"key":"1563_CR26","doi-asserted-by":"publisher","first-page":"20644","DOI":"10.1074\/jbc.M109.083626","volume":"285","author":"P Krejci","year":"2010","unstructured":"Krejci P, Murakami S, Prochazkova J, Trantirek L, Chlebova K, Ouyang Z, Aklian A, Smutny J, Bryja V, Kozubik A, Wilcox WR (2010) NF449 is a novel inhibitor of fibroblast growth factor receptor 3 (FGFR3) signaling active in chondrocytes and multiple myeloma cells. J Biol Chem 285:20644\u201320653","journal-title":"J Biol Chem"},{"key":"1563_CR27","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.yexcr.2004.03.011","volume":"297","author":"P Krejci","year":"2004","unstructured":"Krejci P, Bryja V, Pachernik J, Hampl A, Pogue R, Mekikian P, Wilcox WR (2004) FGF2 inhibits proliferation and alters the cartilage-like phenotype of RCS cells. Exp Cell Res 297:152\u2013164","journal-title":"Exp Cell Res"},{"key":"1563_CR28","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1002\/1529-0131(200101)44:1<85::AID-ANR12>3.0.CO;2-6","volume":"44","author":"C De Bari","year":"2001","unstructured":"De Bari C, Dell\u2019Accio F, Luyten FP (2001) Human periosteum-derived cells maintain phenotypic stability and chondrogenic potential throughout expansion regardless of donor age. Arthritis Rheum 44:85\u201395","journal-title":"Arthritis Rheum"},{"key":"1563_CR29","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1186\/s13023-019-1247-6","volume":"14","author":"C Saint-Laurent","year":"2019","unstructured":"Saint-Laurent C, Garde-Etayo L, Gouze E (2019) Obesity in achondroplasia patients: from evidence to medical monitoring. Orphanet J Rare Dis 14:253","journal-title":"Orphanet J Rare Dis"},{"key":"1563_CR30","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1101\/gad.266551.115","volume":"29","author":"DM Ornitz","year":"2015","unstructured":"Ornitz DM, Marie PJ (2015) Fibroblast growth factor signaling in skeletal development and disease. Genes Dev 29:1463\u20131486","journal-title":"Genes Dev"},{"key":"1563_CR31","doi-asserted-by":"publisher","first-page":"T115","DOI":"10.1530\/JME-17-0298","volume":"61","author":"S Yakar","year":"2018","unstructured":"Yakar S, Werner H, Rosen CJ (2018) Insulin-like growth factors: actions on the skeleton. J Mol Endocrinol 61:T115\u2013T137","journal-title":"J Mol Endocrinol"},{"key":"1563_CR32","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1126\/science.3523759","volume":"233","author":"A Nilsson","year":"1986","unstructured":"Nilsson A, Isgaard J, Lindahl A, Dahlstr\u00f6m A, Skottner A, Isaksson OG (1986) Regulation by growth hormone of number of chondrocytes containing IGF-I in rat growth plate. Science 233:571\u2013574","journal-title":"Science"},{"key":"1563_CR33","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1096\/fasebj.13.14.1985","volume":"13","author":"J Wang","year":"1999","unstructured":"Wang J, Zhou J, Bondy CA (1999) Igf1 promotes longitudinal bone growth by insulin-like actions augmenting chondrocyte hypertrophy. FASEB J 13:1985\u20131990","journal-title":"FASEB J"},{"key":"1563_CR34","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1093\/hmg\/ddp590","volume":"19","author":"N Su","year":"2010","unstructured":"Su N, Sun Q, Li C, Lu X, Qi H, Chen S, Yang J, Du X, Zhao L, He Q, Jin M, Shen Y, Chen D, Chen L (2010) Gain-of-function mutation in FGFR3 in mice leads to decreased bone mass by affecting both osteoblastogenesis and osteoclastogenesis. Hum Mol Genet 19:1199\u20131210","journal-title":"Hum Mol Genet"},{"key":"1563_CR35","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1002\/jbmr.2839","volume":"31","author":"N Su","year":"2016","unstructured":"Su N, Li X, Tang Y, Yang J, Wen X, Guo J, Tang J, Du X, Chen L (2016) Deletion of FGFR3 in osteoclast lineage cells results in increased bone mass in mice by inhibiting osteoclastic bone resorption. J Bone Miner Res 31:1676\u20131687","journal-title":"J Bone Miner Res"},{"key":"1563_CR36","doi-asserted-by":"publisher","first-page":"693","DOI":"10.3389\/fphar.2017.00693","volume":"8","author":"J Guo","year":"2017","unstructured":"Guo J, Li W, Wu Y, Jing X, Huang J, Zhang J, Xiang W, Ren R, Lv Z, Xiao J, Guo F (2017) Meclizine prevents ovariectomy-induced bone loss and inhibits osteoclastogenesis partially by upregulating PXR. Front Pharmacol 8:693","journal-title":"Front Pharmacol"},{"key":"1563_CR37","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1359\/jbmr.2001.16.6.1068","volume":"16","author":"H Li","year":"2001","unstructured":"Li H, Bartold PM, Young WG, Xiao Y, Waters MJ (2001) Growth hormone induces bone morphogenetic proteins and bone-related proteins in the developing rat periodontium. J Bone Miner Res 16:1068\u20131076","journal-title":"J Bone Miner Res"},{"key":"1563_CR38","doi-asserted-by":"publisher","first-page":"8349","DOI":"10.1096\/fj.201802007R","volume":"33","author":"R Fuente","year":"2019","unstructured":"Fuente R, Gil-Pe\u00f1a H, Claramunt-Taberner D, Hern\u00e1ndez-Fr\u00edas O, Fern\u00e1ndez-Iglesias \u00c1, Alonso-Dur\u00e1n L, Rodr\u00edguez-Rubio E, Hermida-Prado F, Anes-Gonz\u00e1lez G, Rubio-Aliaga I, Wagner C, Santos F (2019) MAPK inhibition and growth hormone: a promising therapy in XLH. FASEB J 33:8349\u20138362","journal-title":"FASEB J"},{"key":"1563_CR39","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3892\/etm.2022.11738","volume":"25","author":"Y Kamiya","year":"2022","unstructured":"Kamiya Y, Matsushita M, Mishima K, Ohkawara B, Michigami T, Imagama S, Ohno K, Kitoh H (2022) Meclozine ameliorates bone mineralization and growth plate structure in a mouse model of X linked hypophosphatemia. Exp Ther Med 25:39","journal-title":"Exp Ther Med"},{"key":"1563_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2023.111911","volume":"566\u2013567","author":"VG Piazza","year":"2023","unstructured":"Piazza VG, Cicconi NS, Martinez CS, Dominici FP, Miquet JG, Sotelo AI (2023) Liver impact of growth hormone (GH) intermittent treatment during the growth period in mice. Mol Cell Endocrinol 566\u2013567:111911","journal-title":"Mol Cell Endocrinol"},{"key":"1563_CR41","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1677\/JOE-09-0431","volume":"205","author":"S Perrini","year":"2010","unstructured":"Perrini S, Laviola L, Carreira MC, Cignarelli A, Natalicchio A, Giorgino F (2010) The GH\/IGF1 axis and signaling pathways in the muscle and bone: mechanisms underlying age-related skeletal muscle wasting and osteoporosis. J Endocrinol 205:201\u2013210","journal-title":"J Endocrinol"},{"key":"1563_CR42","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3390\/cells10010129","volume":"10","author":"J Donato Jr","year":"2021","unstructured":"Donato J Jr, Wasinski F, Furigo IC, Metzger M, Fraz\u00e3o R (2021) Central regulation of metabolism by growth hormone. Cells 10:129","journal-title":"Cells"},{"key":"1563_CR43","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1530\/eje.0.1380275","volume":"138","author":"H Tanaka","year":"1998","unstructured":"Tanaka H, Kubo T, Yamate T, Ono T, Kanzaki S, Seino Y (1998) Effect of growth hormone therapy in children with achondroplasia: growth pattern, hypothalamic-pituitary function, and genotype. Eur J Endocrinol 138:275\u2013280","journal-title":"Eur J Endocrinol"}],"container-title":["Journal of Bone and Mineral Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-024-01563-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00774-024-01563-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-024-01563-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T21:12:37Z","timestamp":1744492357000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00774-024-01563-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,8]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["1563"],"URL":"https:\/\/doi.org\/10.1007\/s00774-024-01563-x","relation":{},"ISSN":["0914-8779","1435-5604"],"issn-type":[{"value":"0914-8779","type":"print"},{"value":"1435-5604","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,8]]},"assertion":[{"value":"22 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}